Prevalence of PCOS with Associated Symptoms and Complications at Tertiary Care Hospital of Karachi
Journal of Advances in Medicine and Medical Research,
Aim: The aim of this study is to determine the prevalence of PCOS among different gynecological disorders at tertiary care hospital of Karachi and to assess the most frequent presenting complaint with associated complications among them.
Study Design: Single-centered cross-sectional study.
Place and Duration of Study: Gynecological clinic of Karachi at a Tertiary care Hospital during 3rd December 2018 to 29th March 2019.
Methodology: Total 335 premenopausal women approached the clinic with different gynecological disorders during the period of four months and 305 patients agreed to participate. The patients were enrolled via convenient sampling technique. After taking the informed consent they were evaluated through clinical interviews, questionnaire, and anthropometric measurements. The diagnosis of PCOS was made by using Rotterdam criteria 2003. Menstrual irregularities were assessed via history. Clinical hyperandrogenism was evaluated by using modified Ferriman–Gallwey scale and Acne Global Grading System. Obesity was calculated through BMI. The Hamilton scale was used to appraise associated psychological disturbances.
Results: PCOS was the most prevalent gynecological disorder (55.41%) among women of the premenopausal age. Overall, the most frequent presenting complaint was infertility but age related variations in symptoms showed that young adolescent and adulthood had more menstruation irregularities while, in late adolescent the chief complaint was infertility. Moreover, these patients were either overweight 32% or obese 46.2%. Other associated problems such as anxiety and migraine were more frequent in young adults and juveniles respectively.
Conclusion: PCOS is the most common gynecological problem in our region. These women usually presents with altered complains that influence their physiological and psychological health which in turn effects the quality of life.
- Polycystic ovary syndrome (PCOS)
- associated symptoms and complications.
How to Cite
Brakta S, Lizneva D, Mykhalchenko K, Imam A, Walker W, Diamond MP, et al. Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded? The Journal of Clinical Endocrinology & Metabolism. 2017;102(12):4421-7.
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016;106(1):6-15.
Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, et al. Sleep disturbances in women with polycystic ovary syndrome: Prevalence, pathophysiology, impact and management strategies. Nature and Science of Sleep. 2018;10:45.
Lambertini L, Saul SR, Copperman AB, Hammerstad SS, Yi Z, Lee JA, et al. Intrauterine programming of polycystic ovary syndrome: evidence from cord blood global methylation analysis. Fertility and Sterility. 2017;108(3):e248.
Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. International Journal of Women's Health. 2017;9:1.
Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: Approach to clinical practice. Clinics. 2015;70(11): 765-9.
Tan J, Wang QY, Feng GM, Li XY, Huang W. Increased risk of psychiatric disorders in women with polycystic ovary syndrome in Southwest China. Chinese medical journal. 2017;130(3):262.
Ybarra M, Franco R, Cominato L, Sampaio R, Sucena S, Damiani D, et al, editors. Prevalence and characteristics of polycystic ovary syndrome in obese adolescents. Hormone Research in Paediatrics; Karger Allschwilerstrasse 10, CH-4009 Basel, Switzerland; 2016.
Hacivelioglu S, Gungor ANC, Gencer M, Uysal A, Hizli D, Koc E, et al. Acne severity and the Global Acne Grading System in polycystic ovary syndrome. International Journal of Gynecology & Obstetrics. 2013; 123(1):33-6.
Kashani L, Omidvar T, Farazmand B, Modabbernia A, Ramzanzadeh F, Tehraninejad ES, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology. 2013;38(6): 767-76.
Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: Overview and approaches for treatment. Diabetes Spectrum. 2015;28(2):116-20.
Charalampakis V, Tahrani AA, Helmy A, Gupta JK, Singhal R. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016;207:220-6.
Ganie MA, Kalra S. Polycystic ovary syndrome–A metabolic malady, the mother of all lifestyle disorders in women–Can Indian health budget tackle it in future? Indian Journal of Endocrinology and Metabolism. 2011;15(4):239.
Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: Hormone profiles and clinical findings. Journal of Pakistan Association of Dermatology. 2016;20(4): 194-8.
Boyle JA, Cunningham J, OˈDea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Medical Journal of Australia. 2012;196(1): 62-6.
Baqai Z, Khanam M, Parveen S. Prevalence of PCOS in infertile patients. Medical Channel. 2010;16(3).
Zreik R, Nasrallah MP. The prevalence of endocrinopathies among Lebanese women presenting with hirsutism to an endocrine clinic. Lebanese Medical Journal. 2014; 103(1006):1-6.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology. 2011;9(1):39.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Human Reproduction. 2012; 27(10):3067-73.
Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66(1):33-8.
Gyllensten U, Gustavsson I, Lindell M, Wilander E. Primary high-risk HPV screening for cervical cancer in post-menopausal women. Gynecologic Oncology. 2012;125(2):343-5.
Yamamoto A, Johnstone EB, Bloom MS, Huddleston HG, Fujimoto VY. A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes. Journal of Assisted Reproduction and Genetics. 2017;34(6): 765-74.
Zhai K, Zhuo G, Chi H, Lan Z. Comparisons of prevalence and clinical and environmental characteristics between Tibetan and Han Women with polycystic ovarian syndrome in Tibetan Plateau. Zhonghua Yi Xue Za Zhi. 2017;97(37): 2928-31.
Misso ML, Teede HJ, Hart R, Wong J, Rombauts L, Melder AM, et al. Status of clomiphene citrate and metformin for infertility in PCOS. Trends in Endocrino-logy & Metabolism. 2012;23(10):533-43.
Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. Journal of Women's Health. 2015; 24(4):299-307.
Singh N, Kamat D, Patel P, Tup N. Demographic profile, prevalence and treatment modalities received by patients with polycystic ovarian syndrome: A descriptive study from a rural tertiary care hospital. Nat J Med Dent Res. 2017;5(2): 112-7.
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility. 2012;97(1):28-38.e25.
Krishnan A, Muthusami S. Hormonal alterations in PCOS and its influence on bone metabolism. Journal of Endocrinology. 2017;232(2):R99-R113.
Hsu M-I. Changes in the PCOS phenotype with age. Steroids. 2013;78(8):761-6.
Haq F, Aftab O, Rizvi J. Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome. J Coll Physicians Surg Pak. 2007;17(2):76-80.
Siddiqui IA, Tamimi W, Tamim H, AlEisa N, Adham M. A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome. Archives of gynecology and obstetrics. 2010;281(3):467-71.
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine reviews. 2015;36(5): 487-525.
Lim S, Norman RJ, Davies M, Moran L. The effect of obesity on polycystic ovary syndrome: A systematic review and meta‐analysis. Obesity Reviews. 2013; 14(2):95-109.
Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian Journal of Psychological Medicine. 2018;40(3):239.
Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, et al. Psychosocial factors associated with polycystic ovary syndrome: A case control study. Journal of Caring Sciences. 2015;4(3):225.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine. 2010;8(1):41.
Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, et al. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in Kashmir. Indian Journal of Psychological Medicine. 2015; 37(1):66.
Abstract View: 3671 times
PDF Download: 1020 times